High-efficiency flame retardant behavior of bi-DOPO compound with hydroxyl group on epoxy resin
Sign Up to like & getrecommendations! Published in 2019 at "Polymer Degradation and Stability"
DOI: 10.1016/j.polymdegradstab.2019.06.024
Abstract: Abstract To explore the more effective non-halogen flame retardants in epoxy resins, a flame retardant named ABD owning relatively short bridged bonds and a hydroxyl group was synthesized via addition reaction between acrolein and 9,10-dihydro-9-oxa-10-phosphaphenanthrene… read more here.
Keywords: epoxy resin; hydroxyl group; abd; flame retardant ... See more keywords
Drosophila Hox genes induce melanized pseudo-tumors when misexpressed in hemocytes
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-81472-5
Abstract: Hox genes are early determinants of cell identity along the anterior–posterior body axis across bilaterians. Several late non-homeotic functions of Hox genes have emerged in a variety of processes involved in organogenesis in several organisms,… read more here.
Keywords: gal4; hox genes; group; pseudo tumors ... See more keywords
FRI0338 Therapeutic conformity to guidelines and drug-approval in adamantiades-behcet's disease: a retrospective analysis of a middle-european cohort
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.5070
Abstract: Background Adamantiades-Behcet's disease (ABD) is a chronic systemic vasculitic disease. Because of multiorgan involvement with diagnostic and therapeutic challenges for physicians, treatment decisions can be very difficult. Objectives To retrospectively assess the use of medication… read more here.
Keywords: treatment; middle european; disease; drug ... See more keywords
Index of Authors and Co-Authors
Sign Up to like & getrecommendations! Published in 2019 at "United European Gastroenterology Journal"
DOI: 10.1177/2050640619886524
Abstract: Vol. 7 | October 2019 a A. Diab K.; P1231 A. Faheem H.; P0252, P1639 A. Kasemy Z.; P0156 A. El-Gendy A.-E.A.; P1231 A.P. Hospers G.; OP121 Aadam A.; P1261 Aadam A.A.; OP139 Aalbers A.;… read more here.
Keywords: abd; index authors; abe; authors authors ... See more keywords
Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14030522
Abstract: Targeted drug conjugates based on Affibody molecules fused to an albumin-binding domain (ABD) for half-life extension have demonstrated potent anti-tumor activity in preclinical therapeutic studies. Furthermore, optimization of their molecular design might increase the cytotoxic… read more here.
Keywords: drug conjugates; domain; abd; affibody drug ... See more keywords
Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14081612
Abstract: Overexpression of the human epidermal growth factor receptor 2 (HER2) in breast and gastric cancer is exploited for targeted therapy using monoclonal antibodies and antibody-drug conjugates. Small engineered scaffold proteins, such as the albumin binding… read more here.
Keywords: adapt6 abd; her2; abd mcdm1; abd ... See more keywords